首页 > 最新文献

Journal of clinical & experimental oncology最新文献

英文 中文
Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of Spermatic Cord: A Rare Entity 尤因氏肉瘤/精索原始神经外胚层肿瘤:罕见病例
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110.1000233
S. Kansal, Sanjay Jain, A. Yadav
Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) is an aggressive tumor derived from the neuroectoderm, commonly arising in the bone and soft tissues of the extremities [1,2].  ES/PNET arising in spermatic cord is extremely uncommon. We report a case study of this rare entity highlighting the characteristic histomorphological and immunohistochemical features.
尤文氏肉瘤/原始神经外胚层肿瘤(ES/PNET)是一种源自神经外胚层的侵袭性肿瘤,常见于四肢骨骼和软组织[1,2]。精索内发生ES/PNET极为罕见。我们报告一个病例研究这种罕见的实体突出特征的组织形态学和免疫组织化学特征。
{"title":"Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of Spermatic Cord: A Rare Entity","authors":"S. Kansal, Sanjay Jain, A. Yadav","doi":"10.4172/2324-9110.1000233","DOIUrl":"https://doi.org/10.4172/2324-9110.1000233","url":null,"abstract":"Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) is an aggressive tumor derived from the neuroectoderm, commonly arising in the bone and soft tissues of the extremities [1,2].  ES/PNET arising in spermatic cord is extremely uncommon. We report a case study of this rare entity highlighting the characteristic histomorphological and immunohistochemical features.","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"2018 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70249643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strong immunogenicity of membrane nanovesicles from dendritic cells 树突状细胞膜纳米囊泡的强免疫原性
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-c3-013
J. Sprent
{"title":"Strong immunogenicity of membrane nanovesicles from dendritic cells","authors":"J. Sprent","doi":"10.4172/2324-9110-c3-013","DOIUrl":"https://doi.org/10.4172/2324-9110-c3-013","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abzymes as unique biomarkers and targets to monitor and manage chronic disorders and to serve tools for bioengineering of the next-step generation Abzymes作为监测和管理慢性疾病的独特生物标志物和靶点,并为下一代生物工程提供工具
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-C6-023
S. Suchkov
{"title":"Abzymes as unique biomarkers and targets to monitor and manage chronic disorders and to serve tools for bioengineering of the next-step generation","authors":"S. Suchkov","doi":"10.4172/2324-9110-C6-023","DOIUrl":"https://doi.org/10.4172/2324-9110-C6-023","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasmonic photocatalyst: Hot electron transfer type and hot hole-transfer type 等离子体光催化剂:热电子转移型和热空穴转移型
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-c5-019
S. Naya
{"title":"Plasmonic photocatalyst: Hot electron transfer type and hot hole-transfer type","authors":"S. Naya","doi":"10.4172/2324-9110-c5-019","DOIUrl":"https://doi.org/10.4172/2324-9110-c5-019","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ki67 in young patients with breast cancer 年轻乳腺癌患者的Ki67
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-C6-024
Y. Rahim
{"title":"Ki67 in young patients with breast cancer","authors":"Y. Rahim","doi":"10.4172/2324-9110-C6-024","DOIUrl":"https://doi.org/10.4172/2324-9110-C6-024","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and biological evaluation of new purine-like heterocyclic molecules targeting apoptosis in cancer cell lines 靶向肿瘤细胞凋亡的新型嘌呤样杂环分子的合成及生物学评价
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-c1-009
Kow Koon Kee
{"title":"Synthesis and biological evaluation of new purine-like heterocyclic molecules targeting apoptosis in cancer cell lines","authors":"Kow Koon Kee","doi":"10.4172/2324-9110-c1-009","DOIUrl":"https://doi.org/10.4172/2324-9110-c1-009","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of ribosomal S6 kinase 1 attenuates cell proliferation, migration and invasion of tongue squamous cell carcinoma cells 抑制核糖体S6激酶1可减弱舌鳞癌细胞的增殖、迁移和侵袭
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-C1-008
Ekarat Hitakomate
{"title":"Inhibition of ribosomal S6 kinase 1 attenuates cell proliferation, migration and invasion of tongue squamous cell carcinoma cells","authors":"Ekarat Hitakomate","doi":"10.4172/2324-9110-C1-008","DOIUrl":"https://doi.org/10.4172/2324-9110-C1-008","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manganese-Enhanced Magnetic Resonance Imaging of Breast Cancer Cells 乳腺癌细胞的锰增强磁共振成像
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-c4-017
Mosa Alhamami
{"title":"Manganese-Enhanced Magnetic Resonance Imaging of Breast Cancer Cells","authors":"Mosa Alhamami","doi":"10.4172/2324-9110-c4-017","DOIUrl":"https://doi.org/10.4172/2324-9110-c4-017","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proton accelerated partial breast irradiation (APBI) has an exceptional patient satisfaction profile 质子加速部分乳房照射(APBI)具有特殊的患者满意度概况
Pub Date : 2018-01-01 DOI: 10.4172/2324-9110-c6-022
E. Strom
{"title":"Proton accelerated partial breast irradiation (APBI) has an exceptional patient satisfaction profile","authors":"E. Strom","doi":"10.4172/2324-9110-c6-022","DOIUrl":"https://doi.org/10.4172/2324-9110-c6-022","url":null,"abstract":"","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":"07 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70250462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mantle Cell Lymphoma Misdiagnosed as Chronic Lymphocytic Leukemia: Optimization of Diagnostic Approach Mantle细胞淋巴瘤误诊为慢性淋巴细胞白血病:诊断方法的优化
Pub Date : 2017-12-05 DOI: 10.4172/2324-9110.1000200
Numan Fateh
Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma that is relatively uncommon. MCL is an aggressive lymphoma and at times can share many features with chronic lymphocytic leukemia (CLL). CLL is positive for CD5+ (in 80% of cases), CD20+ (95%) and CD23+ (85%). MCL is also positive for CD5+ (80%) and CD20+ (94%), but generally negative for CD23-. However, there are cases of CD23 positive MCL which can lead to misdiagnosis. Cyclin D1 is more specific than CD markers, but is positive in approximately 85-90% of cases. Thus for 15% of cases this test is also not reliable to diagnose MCL. For example, there are reports of Cyclin D2 and Cyclin D3 involvement instead of the more commonly known Cyclin D1. The same is true for t (11;14) studies by Fluorescence in situ hybridization (FISH) for MCL. Though it is a rare entity, there are known cases of t (11;14) negative MCL. In cases such as these, it may be difficult to correctly diagnose MCL. Therefore, it is important to have an understanding of the similarities and differences of these two diseases and to be aware of the less commonly used tests to help differentiate between MCL and CLL.
套细胞淋巴瘤(MCL)是一种成熟的B细胞非霍奇金淋巴瘤,相对少见。MCL是一种侵袭性淋巴瘤,有时与慢性淋巴细胞白血病(CLL)有许多共同特征。CLL对CD5+(80%)、CD20+(95%)和CD23+(85%)呈阳性。MCL对CD5+(80%)和CD20+(94%)也呈阳性,但通常对CD23-呈阴性。然而,也有CD23阳性MCL的病例会导致误诊。细胞周期蛋白D1比CD标记物更具特异性,但在大约85-90%的病例中呈阳性。因此,对于15%的病例,这种测试也不能可靠地诊断MCL。例如,有报道称细胞周期蛋白D2和细胞周期蛋白D3参与,而不是更常见的细胞周期蛋白D1。对于MCL的荧光原位杂交(FISH)的t(11;14)研究也是如此。尽管它是一种罕见的实体,但已知有t(11;14)阴性MCL的病例。在这种情况下,可能很难正确诊断MCL。因此,重要的是要了解这两种疾病的异同,并了解不太常用的测试方法,以帮助区分MCL和CLL。
{"title":"Mantle Cell Lymphoma Misdiagnosed as Chronic Lymphocytic Leukemia: Optimization of Diagnostic Approach","authors":"Numan Fateh","doi":"10.4172/2324-9110.1000200","DOIUrl":"https://doi.org/10.4172/2324-9110.1000200","url":null,"abstract":"Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma that is relatively uncommon. MCL is an aggressive lymphoma and at times can share many features with chronic lymphocytic leukemia (CLL). CLL is positive for CD5+ (in 80% of cases), CD20+ (95%) and CD23+ (85%). MCL is also positive for CD5+ (80%) and CD20+ (94%), but generally negative for CD23-. However, there are cases of CD23 positive MCL which can lead to misdiagnosis. Cyclin D1 is more specific than CD markers, but is positive in approximately 85-90% of cases. Thus for 15% of cases this test is also not reliable to diagnose MCL. For example, there are reports of Cyclin D2 and Cyclin D3 involvement instead of the more commonly known Cyclin D1. The same is true for t (11;14) studies by Fluorescence in situ hybridization (FISH) for MCL. Though it is a rare entity, there are known cases of t (11;14) negative MCL. In cases such as these, it may be difficult to correctly diagnose MCL. Therefore, it is important to have an understanding of the similarities and differences of these two diseases and to be aware of the less commonly used tests to help differentiate between MCL and CLL.","PeriodicalId":73658,"journal":{"name":"Journal of clinical & experimental oncology","volume":" ","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2017-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47255040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of clinical & experimental oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1